Company patents
Pairwise Plants Services, Inc.
Pairwise Plants Services, Inc. demonstrates a surprising focus on Peptides & Proteins, which constitutes 36.4% of its patent portfolio, despite its name suggesting a primary focus on plants. While New Plants / Plant Reproduction saw a significant 266.7% YoY growth in 2024, both this category and Peptides & Proteins have shown declining patent activity in 2025 and so far in 2026, indicating a potential shift in R&D priorities, further evidenced by the complete cessation of patenting in Genetic & Microbiological Assays in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
118 US filings (since 2023) · 3 categories · 7 themes
Methods and compositions for introducing, modifying, or expressing foreign genetic material within plant cells to confer new traits, produce novel compounds, or enhance existing characteristics.
Engineering or breeding plants to exhibit enhanced resistance or tolerance to pathogens (fungi, bacteria, viruses) or pests, often involving the identification and introduction of specific resistance genes or genomic regions.
Development and characterization of novel plant varieties or cultivars, including field crops, vegetables, fruits, and ornamental plants, focusing on improved agronomic performance, aesthetic qualities, or specific product characteristics.
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Modification of protein or peptide sequences, structures, or post-translational modifications (e.g., glycosylation, lipidation) to enhance their stability, solubility, delivery, or therapeutic efficacy.
In vitro techniques for cultivating plant cells, tissues, or organs under sterile conditions to regenerate whole plants, produce secondary metabolites, or facilitate genetic manipulation.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Patents
Showing 1-10 of 148